Clinical development of advanced therapy medicinal products in Europe: evidence that regulators must be proactive
Mol Ther
.
2012 Mar;20(3):479-82.
doi: 10.1038/mt.2012.13.
Authors
Romaldas Maciulaitis
1
,
Lucia D'Apote
,
Andrew Buchanan
,
Laura Pioppo
,
Christian K Schneider
Affiliation
1
Committee for Advanced Therapies (CAT), European Medicines Agency, London, UK.
PMID:
22378030
PMCID:
PMC3293601
DOI:
10.1038/mt.2012.13
No abstract available
MeSH terms
Europe
Genetic Therapy / legislation & jurisprudence*
Genetic Therapy / methods
Humans